HIMS & HERS HEALTH INC (HIMS)
US4330001060 - Common Stock
We assign a fundamental rating of 4 out of 10 to HIMS. HIMS was compared to 118 industry peers in the Health Care Providers & Services industry. While HIMS has a great health rating, there are worries on its profitability. HIMS is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
HIMS had negative earnings in the past year.
HIMS had a positive operating cash flow in the past year.
HIMS had negative earnings in 4 of the past 5 years.
In the past 5 years HIMS reported 4 times negative operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -5.35%, HIMS is in line with its industry, outperforming 41.03% of the companies in the same industry.
HIMS has a Return On Equity (-6.87%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.35% | ||
| ROE | -6.87% | ||
| ROIC | N/A |
ROA(3y)-16.29%
ROA(5y)-9.96%
ROE(3y)-20.04%
ROE(5y)-12.22%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
HIMS has a better Gross Margin (81.99%) than 95.73% of its industry peers.
HIMS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 81.99% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
HIMS does not have a ROIC to compare to the WACC, probably because it is not profitable.
HIMS has more shares outstanding than it did 1 year ago.
There is no outstanding debt for HIMS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 17.47 indicates that HIMS is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 17.47, HIMS belongs to the best of the industry, outperforming 99.15% of the companies in the same industry.
HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 17.47 |
ROIC/WACCN/A
WACC9.11%
2.3 Liquidity
A Current Ratio of 3.00 indicates that HIMS has no problem at all paying its short term obligations.
HIMS's Current ratio of 3.00 is amongst the best of the industry. HIMS outperforms 84.62% of its industry peers.
A Quick Ratio of 2.74 indicates that HIMS has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.74, HIMS belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3 | ||
| Quick Ratio | 2.74 |
3. Growth
3.1 Past
HIMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 65.63%, which is quite impressive.
HIMS shows a strong growth in Revenue. In the last year, the Revenue has grown by 65.50%.
EPS 1Y (TTM)65.63%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q120%
Revenue 1Y (TTM)65.5%
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2Q47.5%
3.2 Future
Based on estimates for the next years, HIMS will show a very strong growth in Earnings Per Share. The EPS will grow by 65.17% on average per year.
The Revenue is expected to grow by 21.50% on average over the next years. This is a very strong growth
EPS Next Y148.42%
EPS Next 2Y96.85%
EPS Next 3Y73.34%
EPS Next 5Y65.17%
Revenue Next Year36.62%
Revenue Next 2Y30.35%
Revenue Next 3Y27.17%
Revenue Next 5Y21.5%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
HIMS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 228.11, the valuation of HIMS can be described as expensive.
HIMS's Price/Forward Earnings is on the same level as the industry average.
HIMS is valuated expensively when we compare the Price/Forward Earnings ratio to 20.39, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 228.11 |
4.2 Price Multiples
HIMS's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 55.5 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
HIMS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
HIMS's earnings are expected to grow with 73.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y96.85%
EPS Next 3Y73.34%
5. Dividend
5.1 Amount
No dividends for HIMS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
HIMS & HERS HEALTH INC
NYSE:HIMS (5/8/2024, 4:38:07 PM)
After market: 12.14 -0.01 (-0.08%)12.15
-0.2 (-1.62%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.61B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 228.11 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.35% | ||
| ROE | -6.87% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 81.99% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3 | ||
| Quick Ratio | 2.74 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)65.63%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y148.42%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)65.5%
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y